Atrantil

Atrantil is a botanical nutraceutical developed by gastroenterologist Dr. Kenneth Brown and KBS Research to address bloating and abdominal discomfort associated with Irritable Bowel Syndrome (IBS) and Small Intestinal Bacterial Overgrowth (SIBO). It is a patented combination of three natural polyphenols: Peppermint Leaf (*M. balsamea* Willd extract), Quebracho Colorado extract, and Horse Chestnut (*Conker Tree* extract). The product functions as a postbiotic that targets methane-producing archaebacteria in the small intestine. Its mechanism involves peppermint to calm the small bowel, quebracho flavonoids to scavenge hydrogen (a fuel for methane production), and horse chestnut to inhibit the reductase enzyme responsible for methane synthesis. Atrantil has been clinically tested in double-blind and open-label trials, demonstrating over 80% effectiveness in relieving bloating symptoms.

Brand names

Atrantil